Completed

HIV/STD Safer Sex Skills Groups for Women in Drug Treatment Programs - 1

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

Behavior Therapy

Behavioral
Who is being recruted

Behavior Therapy

From 18 to 99 Years

See all eligibility criteria

How is the trial designed

Treatment Study

Phase 3
Interventional
Study Start: May 2004

See protocol details

Summary

Principal SponsorNew York State Psychiatric Institute
Last updated: January 12, 2017
Sourced from a government-validated database.Claim as a partner
Study start date: May 1, 2004Actual date on which the first participant was enrolled.

The purpose of this study is to look at a program for women in drug abuse treatment designed to reduce Human Immunodeficiency Virus/Sexually Transmitted Disease (HIV/STD) risk behaviors and reduce unprotected sexual risk behavior. The proposed trial is intended to test the effectiveness of a proven, manual driven, five-session safer sexual skills building group (SSB) intervention (Schilling et al., 1991; El Bassel and Schilling, 1992) for female patients in MMTP or in drug-free outpatient treatment. The effects of SSB will be compared to a standard group HIV education session (HE). This study uses a 2-group, randomized, parallel-group design to compare a five-session safer sexual skills building group to a single 60-min HIV education session (control condition). The control condition is designed to standardize and simulate the usual care at community clinics.

Official TitleHIV/STD Safer Sex Skills Groups for Women in Drug Treatment Programs 
Principal SponsorNew York State Psychiatric Institute
Last updated: January 12, 2017
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details
541 patients to be enrolledTotal number of participants that the clinical trial aims to recruit.
Treatment Study
These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria
FemaleBiological sex of participants that are eligible to enroll.
From 18 to 99 YearsRange of ages for which participants are eligible to join.
Healthy volunteers not allowedIf individuals who are healthy and do not have the condition being studied can participate.
Conditions
Pathology
Behavior Therapy
Criteria

Adult females (18 years of age or older) in drug abuse treatment at participating Community Treatment Programs are invited to participate.

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Study Objectives
Study Objectives
Primary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.
This study has 12 locations
Suspended
Baart CdpLos Angeles, United StatesSee the location
Suspended
Hartford DispensaryNew Britain, United States
Suspended
Staten Island University HospitalStaten Island, United States
Suspended
Addiction Drug ServicesGreensboro, United States
Completed12 Study Centers